Predict your next investment

Good Therapeutics company logo
HEALTHCARE | Drug Development
goodtherapeutics.com

See what CB Insights has to offer

Founded Year

2016

Stage

Series A - II | Alive

Total Raised

$22.19M

Last Raised

$11M | 1 yr ago

About Good Therapeutics

Good Therapeutics is an early-stage biotechnology company based in Seattle, Washington. Good Therapeutics is developing protein drugs that sense biomarkers and respond with a therapeutic activity.

Good Therapeutics Headquarter Location

454 N 34th St 1st floor

Seattle, Washington, 98103,

United States

425-591-9641

Latest Good Therapeutics News

Good Therapeutics Raises $11M To Develop ‘context Dependent’ Protein Drugs

May 22, 2020

by geekwire.com posted 14minutes ago 3 views Seattle biotech startup Good Therapeutics raised another $11 million to create “context dependent” protein drugs that act only when needed. The 4-year-old company is developing cytokines that regulate their own activity in response to biomarkers and metabolic signals, said CEO John Mulligan. It is focused initially on immuno-oncology applications. The $11 million follows another $11 million cash infusion raised last year to complete a $22 million Series A financing round. Investors include Roche Venture Fund; Rivervest Venture Partners; 3X5 Partners; Digitalis Ventures; and Codon Capital.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Good Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Good Therapeutics is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Good Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Good Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.